FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307967001> ?p ?o ?g. }

• W4307967001 endingPage "248" @default.
• W4307967001 startingPage "241" @default.
• W4307967001 abstract "The present double-blinded placebo-controlled randomized clinical trial evaluated prophylactic use of acetylcysteine for the prevention of liver injury in patients with severe COVID-19 pneumonia under treatment with remdesivir.Liver injury is reportedly common in patients with severe COVID-19 pneumonia and can occur not only as a result of disease progression, but as an iatrogenic reaction to remdesivir.A total of 83 adult patients with severe COVID-19 pneumonia were randomly assigned in parallel groups to receive either acetylcysteine or placebo. All the patients received standard care according to institutional protocols, including remdesivir for a total of five days. One gram acetylcysteine was administered intravenously every 12 hours for 42 patients, and 41 patients received the same volume of 0.9% sodium chloride as placebo (Trial Registration: www.irct.ir identifier, IRCT20210726051995N1).After 5 days, median aspartate transaminase (AST) and alanine transaminase (ALT) levels were significantly lower in the acetylcysteine than in the placebo group. Of those who received the placebo, 30 (73.2%), 4 (9.7%), and 3 (7.3%) patients had serum AST levels elevated between 1-2.5, 2.5-5, and over 5 times the upper limit of normal (ULN), respectively; while in the acetylcysteine group, 33 (78.6%) and 0 patients had AST levels between 1-2.5 and over 2.5 times ULN, respectively (p-value=0.037). In the acetylcysteine group, 23 (54.8%), 1 (2.4%), and 1 (2.4%) patient had serum ALT levels elevated between 1-2.5, 2.5-5, and over 5 times ULN, respectively; in the placebo group, however, 24 (58.5%), 7 (17.1%), and 1 (2.4%) patient had serum ALT levels between 1-2.5, 2.5-5, and over 5 times ULN, respectively (p-value=0.073).Intravenous administration of acetylcysteine significantly prevents liver transaminases elevation and liver injury in seriously ill COVID-19 patients treated with remdesivir." @default.
• W4307967001 created "2022-11-06" @default.
• W4307967001 creator A5042752293 @default.
• W4307967001 creator A5045429297 @default.
• W4307967001 creator A5064668177 @default.
• W4307967001 creator A5064939098 @default.
• W4307967001 creator A5075109982 @default.
• W4307967001 date "2022-01-01" @default.
• W4307967001 modified "2023-09-26" @default.
• W4307967001 title "Efficacy and safety of acetylcysteine for the prevention of liver injury in COVID-19 intensive care unit patients under treatment with remdesivir." @default.
• W4307967001 cites W2157305642 @default.
• W4307967001 cites W2527520152 @default.
• W4307967001 cites W2917943654 @default.
• W4307967001 cites W3001118548 @default.
• W4307967001 cites W3007273493 @default.
• W4307967001 cites W3008028633 @default.
• W4307967001 cites W3008827533 @default.
• W4307967001 cites W3009885589 @default.
• W4307967001 cites W3013653866 @default.
• W4307967001 cites W3016535995 @default.
• W4307967001 cites W3018023298 @default.
• W4307967001 cites W3024705102 @default.
• W4307967001 cites W3025778320 @default.
• W4307967001 cites W3027630905 @default.
• W4307967001 cites W3030752164 @default.
• W4307967001 cites W3037746602 @default.
• W4307967001 cites W3045027513 @default.
• W4307967001 cites W3045952783 @default.
• W4307967001 cites W3048379902 @default.
• W4307967001 cites W3080373477 @default.
• W4307967001 cites W3080718665 @default.
• W4307967001 cites W3082254366 @default.
• W4307967001 cites W3087690274 @default.
• W4307967001 cites W3087845861 @default.
• W4307967001 cites W3089682282 @default.
• W4307967001 cites W3094575957 @default.
• W4307967001 cites W3126436471 @default.
• W4307967001 cites W3179793677 @default.
• W4307967001 doi "https://doi.org/10.22037/ghfbb.v15i3.2565" @default.
• W4307967001 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36311968" @default.
• W4307967001 hasPublicationYear "2022" @default.
• W4307967001 type Work @default.
• W4307967001 citedByCount "0" @default.
• W4307967001 crossrefType "journal-article" @default.
• W4307967001 hasAuthorship W4307967001A5042752293 @default.
• W4307967001 hasAuthorship W4307967001A5045429297 @default.
• W4307967001 hasAuthorship W4307967001A5064668177 @default.
• W4307967001 hasAuthorship W4307967001A5064939098 @default.
• W4307967001 hasAuthorship W4307967001A5075109982 @default.
• W4307967001 hasConcept C126322002 @default.
• W4307967001 hasConcept C141071460 @default.
• W4307967001 hasConcept C142724271 @default.
• W4307967001 hasConcept C160160445 @default.
• W4307967001 hasConcept C168563851 @default.
• W4307967001 hasConcept C181199279 @default.
• W4307967001 hasConcept C185592680 @default.
• W4307967001 hasConcept C204787440 @default.
• W4307967001 hasConcept C27081682 @default.
• W4307967001 hasConcept C2776376669 @default.
• W4307967001 hasConcept C2776637226 @default.
• W4307967001 hasConcept C2776877979 @default.
• W4307967001 hasConcept C2777847592 @default.
• W4307967001 hasConcept C2777914695 @default.
• W4307967001 hasConcept C2778004101 @default.
• W4307967001 hasConcept C2778606649 @default.
• W4307967001 hasConcept C2779679107 @default.
• W4307967001 hasConcept C42219234 @default.
• W4307967001 hasConcept C55493867 @default.
• W4307967001 hasConcept C71924100 @default.
• W4307967001 hasConcept C90924648 @default.
• W4307967001 hasConceptScore W4307967001C126322002 @default.
• W4307967001 hasConceptScore W4307967001C141071460 @default.
• W4307967001 hasConceptScore W4307967001C142724271 @default.
• W4307967001 hasConceptScore W4307967001C160160445 @default.
• W4307967001 hasConceptScore W4307967001C168563851 @default.
• W4307967001 hasConceptScore W4307967001C181199279 @default.
• W4307967001 hasConceptScore W4307967001C185592680 @default.
• W4307967001 hasConceptScore W4307967001C204787440 @default.
• W4307967001 hasConceptScore W4307967001C27081682 @default.
• W4307967001 hasConceptScore W4307967001C2776376669 @default.
• W4307967001 hasConceptScore W4307967001C2776637226 @default.
• W4307967001 hasConceptScore W4307967001C2776877979 @default.
• W4307967001 hasConceptScore W4307967001C2777847592 @default.
• W4307967001 hasConceptScore W4307967001C2777914695 @default.
• W4307967001 hasConceptScore W4307967001C2778004101 @default.
• W4307967001 hasConceptScore W4307967001C2778606649 @default.
• W4307967001 hasConceptScore W4307967001C2779679107 @default.
• W4307967001 hasConceptScore W4307967001C42219234 @default.
• W4307967001 hasConceptScore W4307967001C55493867 @default.
• W4307967001 hasConceptScore W4307967001C71924100 @default.
• W4307967001 hasConceptScore W4307967001C90924648 @default.
• W4307967001 hasIssue "3" @default.
• W4307967001 hasLocation W43079670011 @default.
• W4307967001 hasOpenAccess W4307967001 @default.
• W4307967001 hasPrimaryLocation W43079670011 @default.
• W4307967001 hasRelatedWork W1103173082 @default.
• W4307967001 hasRelatedWork W1988371333 @default.
• W4307967001 hasRelatedWork W2038293264 @default.

• next